A placebo-controlled, randomised trial of the addition of once weekly GLP-1 receptor agonist dulaglutide to titrated daily insulin glargine in patient
本文档由 cyjdoctor 分享于2017-03-22 13:12
A placebo-controlled, randomised trial of the addition of once weekly GLP-1 receptor agonist dulaglutide to titrated daily insulin glargine in patient
分享：
君，已阅读到文档的结尾了呢~~